Design, synthesis, and antiviral properties of 2-aryl-1H-benzimidazole-4-carboxamide derivatives

Abstract

A series of new benzimidazole derivatives were designed and synthesized. Their chemical structures were testified by ¹H NMR, infrared spectroscopy (IR), mass spectrography (MS), and elemental analysis. Their potent antiviral properties indicated the prospect of new drugs. Compound 13, 16, 18, 19, 21, 22, and 23 were identified as novel antivirus with much better selective activity and inhibitory activity than the comparable ribavirin against Coxsackie virus B₃ in VERO cells.

Keywords

benzimidazole / coxsackie virus B₃ / antiviral properties

References

[1] Cheng J, Xie J T, Luo X J. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Bioorg Med Chem Lett, 2005, 15: 267-269

[2] Kristjan G, Richard S P, Aurora R L D. Preparation of (quinolinylaminoalkyl)-benzimidazole derivatives as chemokine receptor ligands with anti-HIV activity. <patent>WO2006023400</patent>

[3] White A W, Almassy T, Calvert A H, Crutin N J, Griffin R J, Hostomsky Z, Maegley K, Newell D R, Srinivasan S, Golding B T. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem, 2000, 43: 4084-4097

[4] Garuti L, Roberti M, Cermelli C. Synthesis and antiviral activity of some N-(benzenesulphonyl)-benzimidazoles. Bioorg Med Chem Lett, 1999, 9: 2525-2530

[5] Garuti L, Roberti M, Clercq E D. Synthesis and antiviral/antiproliferative activity of some N-sulphonyl-benzimidazoles. Bioorg Med Chem Lett, 2002, 12: 2707-2710

[6] Gilbert B E, Knight V. Biochemistry and clinical applications of ribavirin. Agents Chemother, 1986, 30: 201-205

[7] Chapman E, Stephen H J. Preparation of phthalamic acids and their conversion into anthranilic acids. Chem Soc, 1925, 127: 1791-1797

[8] Barkalow J H, Breting J, Gaede B J, Haight A R, Henry R, Kotecki B, Mei J, Pearl K B, Tedrow J S, Viswanath S K. Process Development for ABT-472, a Benzimidazole PARP Inhibitor. Organic Process Research and Development, 2007, 11: 693-698

[9] William A D, Gordon W R, Bruce C B. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of “minimal” DNA-intercalating agents which may not act via topoisomerase II. J Med Chem, 1990, 33: 814-819

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg